Search Results - "Olesen, René K"

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab by Rohrberg, Kristoffer Staal, Pappot, Helle, Lassen, Ulrik, Westman, Maj, Olesen, René K., Pfeiffer, Per, Ladekarl, Morten, Sørensen, Morten, Christensen, Ib J., Skov, Birgit G.

“…Malignancies in the upper gastrointestinal (UGI) tract are amongst the most aggressive cancers and only few treatment options exist. We have recently analysed…”
Get full text

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers by Rohrberg, Kristoffer S, Olesen, René K, Pfeiffer, Per, Ladekarl, Morten, Pappot, Helle, Christensen, Ib J, Høyer-Hansen, Gunilla, Sørensen, Morten, Skov, Birgit G, Buysschaert, Ian, Carmeliet, Peter, Lassen, Ulrik

“…Patients with upper gastrointestinal cancers have a poor prognosis and only few treatment options. The epidermal growth factor receptor (EGFR) and vascular…”
Get more information

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial by Iveson, Timothy J, Kerr, Rachel S, Saunders, Mark P, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Scudder, Claire, Boyd, Kathleen Anne, Briggs, Andrew, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James

“…6 months of oxaliplatin-containing chemotherapy is usually given as adjuvant treatment for stage 3 colorectal cancer. We investigated whether 3 months of…”
Get full text

Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial by Gögenur, Mikail, Rosen, Andreas Weinberger, Iveson, Timothy, Kerr, Rachel S, Saunders, Mark P, Cassidy, Jim, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, Pearson, Sarah, Boyd, Kathleen A, Briggs, Andrew H, Waterston, Ashita, Medley, Louise, Ellis, Richard, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Cunningham, David, Hickish, Tamas, Gollins, Simon, Wasan, Harpreet S, Kelly, Caroline, Gögenur, Ismail, Holländer, Niels Henrik

“…The timing of adjuvant chemotherapy after surgery for colorectal cancer and its association with long-term outcomes have been investigated in national cohort…”
Get more information

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer by Robles-Zurita, José, Boyd, Kathleen A., Briggs, Andrew H., Iveson, Timothy, Kerr, Rachel S., Saunders, Mark P., Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Segelov, Eva, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Pearson, Sarah, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S., Hughes, Rob, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James

“…BACKGROUND The Short Course Oncology Therapy (SCOT) study is an international, multicentre, non-inferiority randomised controlled trial assessing the efficacy,…”
Get full text

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT by Iveson, Timothy, Boyd, Kathleen A, Kerr, Rachel S, Robles-Zurita, Jose, Saunders, Mark P, Briggs, Andrew H, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Pearson, Sarah, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet, Paul, James

“…Oxaliplatin and fluoropyrimidine chemotherapy administered over 6 months is the standard adjuvant regimen for patients with high-risk stage II or III…”
Get full text

Tumor specific methylation of NPY compared to RAS mutation in plasma DNA in the monitoring of colorectal cancer patients treated with last-line regorafenib by Jensen, Lars Henrik, Thomsen, Caroline Brenner, Olesen, Rene K, Boysen, Anders Kindberg, Hansen, Torben, Nottelmann, Lise, Havelund, Birgitte Mayland, Andersen, Rikke Fredslund, Jakobsen, Anders Kristian Moeller

“…Abstract only…”
Get full text